n Southern African Journal of HIV Medicine - FDA Public advisory for Nevirapine (Viramune) : public health
|Article Title||FDA Public advisory for Nevirapine (Viramune) : public health|
|Journal||Southern African Journal of HIV Medicine|
|Publication Date||Mar 2005|
|Pages||10 - 11|
Extracted from text ... MARCH 2005 THE SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE 10 FDA Public advisory for Nevirapine (Viramune) PUBLIC HEALTH Recently the US Federal Drug Administration has issued a Public Advisory for Nevirapine (NVP) (Vira-mune) informing health care providers of a safety-related change to the nevirapine package insert. This advisory, issued on 19 January 2005, notified a change in nevirapine prescribing information with a warning against starting nevirapine in women with CD4 counts > 250 cells/?l and in men with counts > 400/?l. The risk of developing a hepatic hypersensitivity reaction in the first 6 weeks of nevirapine therapy had been shown ..
Article metrics loading...